Belgium: GE HealthCare strengthening neurology portfolio with acquisition of icometrix

Nasdaq-listed GE HealthCare is to acquire icometrix, a Belgium-based company focused on providing AI-powered brain imaging analysis for neurological disorders. The acquisition addresses the growing demand for more frequent neurological MRI exams.

Founded in 2011, icometrix provides AI-powered brain imaging analysis through its icobrain platform, offering clinicians valuable insights into neurological disorders.

To complement its MR-guided AI-assisted scanning expertise with analysis and reporting in neurological disease assessment, GE HealthCare expects to integrate the icometrix icobrain platform with its MRI systems for seamless workflow. icobrain aria includes the first FDA-cleared computer-aided detection and diagnosis solution for detecting and quantifying known side effects of amyloid targeting therapies – Amyloid Related Imaging Abnormalities (ARIA). 

“This effort marks a pivotal step in our journey to advance precision care in neurology,” said Roland Rott, president and CEO, Imaging at GE HealthCare. “By integrating icometrix’s AI-powered insights with our advanced imaging technologies, we aim to empower care teams with the clarity and confidence needed to navigate complex neurological conditions.”

GE’s current neuro solutions portfolio, including MR and PET scanners, pharmaceutical diagnostics and MIMneuro Software digital solutions that support quantification for amyloid imaging, enables it to offer holistic neuro solutions for its customers.

The icometrix suite of solutions includes tools that assist radiologists and neurologists with comparing and quantifying brain MR scans over time for disorders ranging from multiple sclerosis, dementia, epilepsy, stroke and traumatic brain injury, among others. This product suite also features a strong pipeline of clinical decision support applications in development to improve neurological care in the future.

“We are excited by the prospect of joining GE HealthCare and leveraging icometrix’ innovation talents and customer relationships to continue to improve the diagnostic and treatment journey for both neurological clinicians and their patients,” said Wim Van Hecke, icometrix CEO.

In 2019, icometrix raised US$18m in a financing round led by Forestay Capital alongside Optum Ventures and existing investor Capricorn Venture Partners.

Stifel served as exclusive financial advisor to icometrix. The Stifel team: Ben Maddison Kate Hanshaw Erik Klein Wassink  

Press release: GE HealthCare announces intent to acquire icometrix to strengthen neurology portfolio with brain MRI assessment solutions